Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 2,000 shares at $37.47 ($74,940)
  2. 4 Grant or award Director acquired 559 shares (grant or award)
  3. 4 Grant or award Director acquired 164 shares (grant or award)
  4. 4 Grant or award Director acquired 164 shares (grant or award)
  5. 4 Grant or award Director acquired 328 shares (grant or award)
  6. 4 Grant or award Director acquired 328 shares (grant or award)
  7. 4 Planned sale President & CEO sold 5,000 shares at $38.15 ($190,750)
  8. 144 Insider Sale of Securities
  9. 4 Planned sale EVP Research & Development sold 2,000 shares at $33.76 ($67,520)
  10. 4 Planned sale President & CEO sold 5,000 shares at $33.55 ($167,750)
  11. 4 Planned sale EVP Research & Development sold 2,000 shares at $32.91 ($65,820)
  12. 4 Planned sale President & CEO sold 5,000 shares at $33.80 ($169,000)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 4 Planned sale Director sold 3,636 shares at $32.10 ($116,716)
  16. 4 Planned sale EVP, Chief Commercial Officer sold 8,659 shares at $32.04 ($277,434)
  17. 4 Planned sale EVP Research & Development sold 2,000 shares at $31.88 ($63,760)
  18. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,965 shares (to pay taxes)
  19. 4 Planned sale President & CEO sold 5,000 shares at $31.22 ($156,100)
  20. 4 Planned sale EVP Research & Development sold 2,000 shares at $31.98 ($63,960)

Page 13 of 127 · 2,534 filings